Dr. Jason Fung, MD, believes that targeting fat distribution via INHBE is beneficial for overall metabolic health

The prevalence of comorbidity in patients with obesity is high, which can have severe health implications. Nephrologist and best-selling author of The Obesity Code, Dr. Jason Fung, MD, believes that targeting fat distribution via INHBE is beneficial for overall metabolic health. This highlights Vial’s INHBE siRNA program as a promising therapeutic approach to not only improve the quality of fat loss but also address the overall distribution of fat.

Discover Vial’s INHBE siRNA program: vial.com/inhbe-activin-e/

View on Linkedin

More Resources

Videos

Dr. Jens Juul Holst, Professor at the Department of Biomedical Sciences and Senior Group Leader at Novo Nordisk Foundation Center for Basic Metabolic Research on the next breakthroughs in obesity treatment.

Videos

Dr. Scott Kahan, Director of the National Center for Weight and Wellness at Johns Hopkins Bloomberg School of Public Health, highlights the importance of new mechanisms of action beyond GLP-1 therapies.

Videos

Dr. Arya M. Sharma, MD, DSc (hon), FRCPC, FCAHS, Emeritus Professor of Medicine at the University of Alberta, highlights INHBE as a promising new target for obesity, acting on both adipocytes and hepatocytes to drive fat-selective weight loss.

Connect with us.

Interested in receiving a proposal from Vial? Leave us a message and some of your contact info and we’ll be in touch with you shortly.

URL

This field is for validation purposes and should be left unchanged.

Name(Required)

Work email(Required)

Phone

Company(Required)

Which best describes you?(Required)

Message

By submitting, you are agreeing to our terms and privacy policy